21-Mar-17 Israel's EyeYon Medical has raised USD6.5 mn to develop, test, and seek regulatory approval for its two main solutions: EndoArt, an artificial endothelial layer which can replace the need for cadaver based implants, and Hyper CLTM, a therapeutic soft contact lens. The investment was led by China-based VC Rimonci Capital and Gauss Group, with existing investors Triventures and Pontifax. [image: Globes]
Read More
21-Mar-17 The National Telehealth Center (NTHC) in the Philippines is tasked with pushing adoption of ICT, including EMR, in the 2,500 government-funded health facilities. Around 1,000 of them are using EMR and the NTHC is partnering with government and non-government institutions in many areas of eHealth to push for deployment of EMR and other solution throughout the Philippines. [image: NTHC]
Read More
21-Mar-17 Researchers at Sandia National Laboratories in the US have developed a smartphone-controlled, battery-operated, diagnostic device for the detection of Zika, dengue, and chikungunya. The new device eliminates the need for laboratory testing and reduces wait times from several days, to around 30 minutes and would cost in the region of USD100. [image: ET Healthworld]
Read More
21-Mar-17 Korea's NongHyup Life Insurance has signed an MOU with KT to develop new insurance products and healthcare services using big data and IoT. The companies will launch a product for elderly people in 2018. The product is characterized by smart bands checking their pulse and movements and providing notifications for families, insurers and public health centers. [image: Business Korea]
Read More
21-Mar-17 Indonesia's Siloam International Hospitals aims to double its hospitals to 50 by 2019. The country's largest hospital operator expects to expand into remote areas, including New Guinea, now that the universal healthcare system allows low-income people to seek medical treatment. The company will also look to expand via acquisitions. [image: Shinya Sawai]
Read MoreGlobal Growth Markets is an intelligence, advisory and local execution firm helping clients identify opportunities, secure capital and grow their business.
We believe the only way to understand a market properly is on the ground. Our in-country experts, combined with AI-optimized analysis, give you a competitive advantage in over 40 markets across the Americas, EMEA and Asia-Pacific.
Our clients benefit from strategic insights, reduced risk and operational support, giving them the confidence to succeed in their global growth markets.
Value for money – real results at affordable rates
Work led by senior directors with >20 years track record
In-country presence across the Americas, EMEA and Asia-Pacific
Investor and private capital network built over decades
Proven frameworks for reliable insights and pragmatic advice
Boots on the ground supporting local execution
Find out more about our intelligence, advisory and execution services
Get in touch to discuss your growth markets needs:
Email: info@ggmkts.com
Follow us: